Program-at-a-Glance

Time	Monday, February 26	Tuesday, February 27	Wednesday, February 28
7 am- 7 pm	Poster Halls open 7 am to 7 pm Monday through Wednesday All posters will be available for viewing for the duration of the conference
1-4 pm	Poster Sessions
	Co-Reptors and Tropism HTLV-I and GB Virus C Virus-Cell Interactions: Co-Receptor Usage Accessory Genes T-Cell Responses and Viral Escape Genetic Diversity in Early HIV Infection: Incidence and Implications <also a Poster Discussion on Tuesday> Cellular and Humoral Immunopathogenesis of Acute HIV Infection Neuropathogenesis: Experimental Therapeutics Neuropathogenesis: Clinical Studies Neurocognitive Dysfunction: Immunologic Mechanisms, Biomarkers, and CNS Drug Penetration <also a Poster Discussion on Wednesday> Immunology of CD4 Cells Immunology of CD8 Cells T-Cell Vaccine Design: New Vectors and Preclinical Testing New RTIs and PIs Targeting CCR5 and CXCR4 Novel Targets Clinical Trials of Entry Inhibitors Clinical Pharmacology in Adults and Children: Issues of Relevance for Developing Countries <also a Poster Discussion on Tuesday> NRTI Resistance: New Drugs, Mutations, Mechanisms, and in vitro Dynamics Novel Mechanisms of Resistance to PIs Resistance to Entry Inhibitors: Novel Agents, CCR5 Antagonists, and In Vitro Dynamics Transmitted Drug Resistance: Epidemiology and Pathogenesis Drug Resistance following First-Line ART <also a Poster Discussion on Tuesday> Diagnostics Quantification of HIV RNA in Resource-Limited Settings Genotypic Characterization of the Viral Envelope Immunology of HIV Infection in Children ART and Hepatoxicity HIV-Associated Nephropathy and other Nephrotoxicity Disease Tenofovir-Associated Renal Dysfunction Osteopenia and Osteoporosis Vaccination against Hepatitis A or B Viruses in HIV Infected Persons Acute HCV Infection: Epidemiology and Immunology Hepatitis Treatment Topics Morbidity and Mortality of HIV Infection HIV Transmission Risk Chemoprophylaxis of Transmission	Intermediaries in Virus-Cell Interaction <also a Poster Discussion on Wednesday> Virology: Cellular Co-factors Viral Replication Molecular Epidemiology of HIV: Detection Methods and Tracking of Spread Impact of HAART on Reservoirs Correlates of Pathogenesis Hallmarks of Pathogenic and Nonpathogenic Infection <also a Poster Discussion on Monday> Neuropathogenesis: Clinical Correlates and Observational Studies T-Regulatory Cells <also a Poster Discussion on Monday> Immunology of NK Cells Viral Envelope, Antibodies, and B Cells Clinical Trials of RTIs Predictors of Immunologic Recovery on ART Predictors of ART Discontinuation, Virologic Response, and Outcomes HIV Care and Treatment in Resource-Limited Settings: Challenges and Outcomes <also a Poster Discussion on Wednesday> Effectiveness of ART in Resource-Limited Settings Clinical Pharmacology of NRTIs, NNRTIs and Integrase Inhibitors Clinical Pharmacology of HIV PIs Clinical Pharmacology of Entry Inhibitors Novel RTI Resistance Mutations, and their Interactions <also a Poster Discussion on Wednesday> Resistance and Hypersusceptability to NNRTIs Resistance and Viral Fitness: Mechanism and Clinical Impact HIV Drug Resistance: Prediction of Emergence Emergence of HIV Drug Resistance in Developing Nations Pharmacokinetics, Safety, and Efficacy of ART in Infants, Children, and Adolescents Strategies of ART in Children Response to ART in Infants, Children, and Adolescents Predictors of Response to ART in Children ART Safety during Pregnancy and Post Partum Risk Factors for MTCT MTCT and Response to ART during Pregnancy Outcomes following PMTCT Factors Associated with Breastfeeding Transmission Impact of Breastfeeding Cessation Outcomes following Early Cessation of Breastfeeding <also a Poster Discussion on Monday> Complications of ART in Resource-Limited Settings <also a Poster Discussion on Monday> ART-Associated Toxicities in Resource-Limited and Developed Countries Lipoatrophy and Mitochondrial Dysfunction Cardiovascular, Lipid, and Metabolic Complications of ART OIs: Incidence, Pathogenesis, and Treatment Invasive Bacterial Infections Incidence of Cancer in HIV Infection Lymphoma and Kaposi’s Sarcoma Pathogenesis and Impact of Treatment Impact of HBV or HCV on Disease Progression in HIV-Infected Persons Effects of ART on Liver Disease in HBV or HCV Co-Infected Persons Behavioral Aspects of HIV Infection and Diagnosis HIV Transmission Factors Microbicides: Pre-clinical, in vitro, ex vitro, and Modeling Studies	Cellular Restrictions Genetic Analysis of Viral Diversity Virology: Zoonotic Infections Cellular Factors Impacting Virus Replication Cellular Reservoirs and Viral Persistence Viral Pathogenesis of Primary Infection Diagnosis of Acute and Chronic HIV Infection ART Treatment during Acute Infection Neuropathogenesis: Virology and Immunology Antigen Presenting Cells and Toll-Like Receptors Special Issues in Immunopathogenesis Vaccines: Neutralizing Antibodies and Clinical Trials Immune-Based Therapies Targeting HIV Reservoirs Treatment Interruptions and Simplification Pharmacogenomics Drug Interactions Predicting Virologic Response to PIs HIV Integrase: Natural Variation and Resistance to Inhibitors Drug Resistance: Diagnostics and Special Compartments Drug Resistance: Special Populations and Outcomes Diagnostics Detection of HIV Infection in Neonatals Diagnostics Detection of Viruses and Antibodies in Bodily Fluids Other than Blood Strategies for Diagnosis of HIV Infection in Infants and Children Risk of HIV Infection in Youth Risk of Disease Progression in HIV-Infected Children Complications of HIV Infection and ART in HIV-Exposed and -Infected Children Pharmacokinetics of ARVs in Pregnancy and Delivery Outcomes and Complications of HIV Infection in Women HIV Infection in Women: Special Issues Pharmacokinetics of ARVs in Women HIV-Related TB: Incidence and Strategies for Prevention of Active Disease HIV-Related TB: Diagnosis, Treatment, and Pathogenesis TB and HIV Co-Infection: Detection and Treatment Challenges <also a Poster Discussion on Tuesday> HIV and Sexually Transmitted Infections Antiviral Chemotherapy of HCV Infection Noninvasive Assessment of Liver Damage Issues in Detection of HIV Infection
2-3 pm	Poster Discussions
	T-Regulatory Cells Outcomes following Early Cessation of Breastfeeding Hallmarks of Pathogenic and Nonpathogenic Infection Complications of ART in Resource-Limited Settings	Clinical Pharmacology in Adults and Children: Issues of Relevance Genetic Diversity in Early HIV Infection: Incidence and Implications TB and HIV Co-Infection: Detection and Treatment Challenges Drug Resistance following First-Line ART	Neurocognitive Dysfunction: Immunologic Mechanisms, Biomarkers, and CNS Drug Penetration Intermediaries in Virus-Cell Interaction HIV Care and Treatment in Resource-Limited Settings: Challenges and Outcomes Novel RTI Resistance Mutations and their Interactions

© CROI. All Rights Reserved. Updated as of 8/5/2010 9:37:25 AM.